JPRN-UMIN000042301招募中未知
Clinical Research regarding allogeneic cell bank for regenerative medicine - Clinical Research regarding allogeneic cell bank for regenerative medicine
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 12years-old 至 25years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients suffering from and having treatment history of infectious diseases such as treponema pallidum, chlamydia, gonorrhea, mycobacterium tuberculosis. 2. Patients with sepsis and suspected sepsis. 3. Patients with treatment history of malignant tumors. 4. Patients with serious metabolic disorders. 5. Patients with endocrine disorders. 6. Patients with collagen disease. 7. Patients with blood dyscrasia. 8. Patients with liver disease. 9. Patients with transmissible spongiform encephalopathy and suspected. Patients with suspected dementia. 10. Patients with a specific genetic disorder or family history. 11. Patients who have had blood transfusions. 12. Patients who have had a transplant. 13. Patients who are determined to be inappropriate as a research subject.
研究者
相似试验
招募中
1 期
Activated NK cell therapy to negate MRD in AML patientsAcute myeloid leukemia.C92.0Acute myeloblastic leukemiaIRCT20230801058996N3Shahid Beheshti University of Medical Sciences15
进行中（未招募）
不适用
Allogeneic Haematopoietic Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Patients with Refractory ?Triple Negative? Breast Cancer - NDPatients with Refractory ?Triple Negative? Breast CancerMedDRA version: 9.1Level: LLTClassification code 10006187Term: Breast cancerEUCTR2008-006262-28-ITISTITUTO EUROPEO DI ONCOLOGIA
已完成
3 期
Phase III Clinical Study of Allogeneic Stem CellTransplantation with Reduced Conditioning (RICT)versus Best Standard of Care in Acute Myeloid Leukemia(AML) in First Complete RemissioAcute Myeloid LeukaemiaCancer - Leukaemia - Acute leukaemiaACTRN12614000351617Australasian Leukaemia & Lymphoma Group (ALLG)14
已完成
2 期
A prospective clinical phase II study of allogeneic stem cell transplantation using conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for patients with acute lymphoblastic leukemia.JPRN-UMIN000001672Department of Hematology and Oncology, Hokkaido University Graduate School of Medicine50
进行中（未招募）
不适用
Allogeneic Hematopoietic Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Patients with Hematologic Malignancies - NDPreparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Patients with Hematologic MalignanciesMedDRA version: 6.1Level: PTClassification code 10028228EUCTR2007-005563-10-ITFONDAZIONE NEOPLASIE SANGUE ONLUS